Jump to content
  • Sign Up
0
Scott Adams

BioLineRx Announces Publication of Pre-Clinical Results Demonstrating Efficacy ... - Bradenton Herald

Rate this topic

Recommended Posts

BioLineRx Announces Publication of Pre-Clinical Results Demonstrating Efficacy ...

Bradenton Herald

BioLineRx (NASDAQ: BLRX)(TASE: BLRX), a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×